In the foundational lesson of Terry’s Corner , Dr. Terry Kenakin invites us to challenge outdated assumptions and step into a new era of drug discovery. Now, Terry is opening the vault. This isn’t theory. Join Terry’s Corner and stay updated on the latest in GPCR research—delivered in a format that’s as approachable Unlock "Why Terry's Corner" now

One of its first pillars, Terry’s Pharmacology Corner , led by Dr. Terry Kenakin , continues to grow. Through Terry’s Pharmacology Corner , he shares decades of expertise in an accessible, on-demand format Kenakin. We’re fortunate to partner with Dr. Terry Kenakin , a pioneer who helped shape modern pharmacology and deepen our understanding of GPCR function

Terry Kenakin is launching a new learning space with video courses, AMAs, and practical insights . Get a sneak peek  and sign up for The Kenakin Brief—his free weekly newslette r.   Terry’s Corner is coming soon. Dr. Terry Kenakin. You can already explore the platform and subscribe to The Kenakin Brief—our new newsletter packed with

Terry Kenakin on how allostery and biased signaling rewrote receptor pharmacology, and why the assay Terry Kenakin's career tracks what happened when that picture came apart. ABOUT TERRY Terry Kenakin is a professor in the Department of Pharmacology at the University of North /profile/Terry-Kenakin - PubMed: https://pubmed.ncbi.nlm.nih.gov/? q=Terry+Kenakin Unlock the Full Dr.

Home Courses Articles About Log In / Sign Up Equip Your Team with Terry Kenakin’s Pharmacology Frameworks • Pharmacology frameworks used in modern drug discovery • Monthly live AMA discussions with Terry Kenakin • Ongoing Terry’s Corner lessons and analysis • Ability to suggest topics relevant to your programs Contact us at Hello@DGPCR.org Terry’s Pharmacology Corner — Created by Dr. Terry Kenakin , powered by Dr. GPCR . Stay connected on LinkedIn and YouTube .

Terry Kenakin on tuning GPCR system sensitivity to reveal true drug activity. September 24, 2026. Terry Kenakin shows how tuning receptor expression separates affinity from efficacy, unmasks hidden agonism Terry Kenakin will show how reducing sensitivity lets you measure affinity and relative efficacy and Terry Kenakin Professor of Pharmacology and Pharmacology Course Coordinator Department of Pharmacology Kenakin trained in chemistry and pharmacology at the University of Alberta and completed postdoctoral